Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Warfarin Prescribers: Cardiologists(?)

Council Members in this Study Group: 16

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Michael Kim, MD
Associate Professor
Feinberg School of Medicine, Northwestern University

Michael Kim, MD, is an Associate Professor at Feinberg School of Medicine, Northwestern University, Illinois. He has served as a Cardiac Electrophysiologist at Health Partners and Regions Hospital in Minnesota and also as an Associate Professor at the University of Minnesota. Dr. Kim has expertise in...

Ramin Ebrahimi, MD
Director of Cardiac Catheterization Lab
Wadsworth VA Medical Center

Ramin Ebrahimi, MD, is Associate Clinical Professor at the University of California in Los Angeles. He is also Director of the Cardiac Catheterization Laboratory and Assistant Director of Nuclear Cardiology at the Wadsworth VA Medical Center. Dr. Ebrahimi’s clinical and research interests focus on interventional...

Bernard Chaitman, MD, Professor and Director, SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINEBernard Chaitman, MD
Professor and Director
SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE

Bernard Chaitman, MD, is Professor of Internal Medicine and Director of Cardiovascular Research at the St. Louis University School of Medicine in Missouri. He is also the Director of the Core ECG Laboratory. Dr. Chaitman has research interests in anti-anginal drug therapies, including Ranolazine, Nicorandil,...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

It is well known that the addition of thiazide diuretic to ACEI or ARB treatment adds about 10 mm Hg reduction on top of the 10 mm Hg reduction provided by the ACEI or ARB agent.  It is expected that blocking renin in the renin angiotensin system with Tekturna would provide a similar result.

TRITON-TIMI 38 study of 13,608 patients with ACS compared prasugrel against clopidogrel, combined with aspirin.  Prasugrel reduced the combined rate of CV death, MI or stroke (12.1% for clopidogrel vs. 9.9% for prasugrel). The benefit came at a cost of increased serious bleeding (1.4%, vs....

Analysis of: Schering releases ENHANCE data today | www.tradingmarkets.com

Physicians have several possible conclusions that can be taken; These include: - the trial is flawed - the selection of patients with much less CIMT than previous trials such as ASAP and ARBITER flaws the study -  the failure to meet the trial endpoint is only a surrogate and clinical trial data...

November 23, 2007
Risk Versus Benefit
By Ramin Ebrahimi, MD, Director of Cardiac Catheterization Lab, Wadsworth VA Medical Center

The pooled analysis of Rimonabant trials point to a significant increase in psychiatric disorders. These studies also point to significant improvements in markers of cardiovascular risk. Risks versus benefits must be considered before the final decision is made on this class of medications.

By Ramin Ebrahimi, MD, Director of Cardiac Catheterization Lab, Wadsworth VA Medical Center

The repositioning of the hole, also present with the VIP version is a mild improvement to decrease sheath manipulation. Otherwise the device has not changed much in the past few years. While a very good device in general, its primary limitaions listed below still remain. 1. not allowing re-access...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Lab, Academic Medical Center
  • Non-Academic Community Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Director
  • Physician - Division Head

GLG's 850+ Clients Include:

Fortune 500®  companies
40 of the leading 50  global mutual funds
15 of the leading 20  global banks
8 of the leading 10  global private equity firms
5 of the top 10  AmLaw firms

Analytics


Generated at 2009-01-08T19:00:17.880